Features
To Pay or Not to Pay: Supreme Court to Consider Whether Patent Licensee in Good Standing May Challenge Patent Validity
Should a patent licensee who fully complies with the terms of its license be precluded from bringing a declaratory judgment action against the patent owner in order to challenge the validity of the patent? On Feb. 21, 2006, the Supreme Court granted certiorari in <i>MedImmune, Inc. v. Genentech, Inc.</i>, 126 S. Ct. 1329 (2006), to consider this precise question.
Features
Admissibility of Settlement Communications in Patent Infringement Rule 11 Proceedings
Plaintiffs bringing patent infringement cases should ensure that they have made an adequate pre-filing inquiry as to the viability of their claims before initiating litigation. Without such an investigation, plaintiffs and their attorneys risk sanctions under Rule 11 of the Federal Rules of Civil Procedure. In the sanctions context, Rule 408 of the Federal Rules of Evidence does not protect settlement communications from admissibility.
Case Briefs
Highlights of the latest insurance cases from around the country.
Personal Injury Coverage: A Historical Perspective: The Duty to Defend False, Fraudulent, and Frivolous Claims
During recent years, personal and advertising injury coverage has been the subject of many court decisions. Often those decisions have involved questions of coverage for copyright infringement under the 'advertising injury' prong of the coverage. However, there has been a wide range of cases involving issues under the 'personal injury' prong of the coverage. In many of these cases, courts have focused on the current wording of the language, without reference to the historical background of the personal injury provisions. That background demonstrates the breadth of the coverage.
Does It Really Matter Who Pays?
After a liability insurance company denies coverage for a lawsuit filed against its policyholder, the policyholder is left to manage the defense and settlement of the lawsuit. Sometimes, the policyholder is forced to, or elects to, have another person or entity pay for the defense fees, settlement, or judgment. This leads to the inevitable question of whether the policyholder can recover from its liability insurer sums paid for defense fees, settlement, or judgment if, after the insurance company has wrongfully denied coverage, the policyholder's defense bills, settlement, or a judgment are paid for by a non-insured person or entity. While it should not matter who pays once a liability insurer has breached its contract, some courts have denied policyholders recoveries when a non-insured third-party steps in for the breaching liability insurer and pays the policyholder's defense fees, a settlement, or the judgment.
Features
Verdicts
Recent rulings of interest to you and your practice.
Accidents Don't Just Happen
As we have discussed in Parts One and Two, there are many well-understood reasons medical mistakes are made ' lack of communication between providers and patients, inattention to detail, placing profit above patient care, and so forth.If we examine all these reasons for medical negligence while looking specifically at health care providers ' why a particular practitioner makes a mistake ' I find that mistakes often happen because doctors, nurses and others in the medical professions 'are' who they are, as people. It is a 'people phenomenon' ' a function of personality that manifests itself in the way a person works.
Features
FDA's New Labeling Rule
On Jan. 18, 2006, the U.S. Food and Drug Administration (FDA) issued a final rule to revise the required format of prescription drug labels so as to enable physicians to find the information they need more readily. New features include a section called 'Highlights' and a Table of Contents. According to the FDA's press release, this is the first time in 25 years that the labeling requirements have undergone a major revision.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Strategy vs. Tactics: Two Sides of a Difficult CoinWith each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Disney-OpenAI’s Sora Deal: What it Signals for Licensing and Responsible AIThe Walt Disney Co.’s newly announced, three-year licensing agreement with OpenAI to bring more than 200 characters from Disney, Marvel, Pixar and Star Wars to Sora marks a pivotal moment at the intersection of intellectual property and generative AI. For rights holders, platforms, and brands, the deal illustrates an emerging blueprint for commercializing iconic IP in AI-native formats while attempting to manage legal, regulatory, and reputational risk.Read More ›
